• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

PODCAST: Incentives to encourage adherence, part 4

In this last part of our discussion on patient adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes.

 

In this last part of our discussion on patient adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes. They discuss a method for developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area. Dr. Feldman is a professor of dermatology at the Wake Forest University School of Medicine, Winston-Salem, N.C.

 

Listen to more in this series:

The importance of patient adherence, part 1

Positively influence patient adherence, part 2

Using surveys to improve patient relations, part 3

 

 

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
4 experts are featured in this series.
2 experts in this video
© 2025 MJH Life Sciences

All rights reserved.